Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
311 Leser
Artikel bewerten:
(1)

Microarray Analysis Market to Surpass $9,011.1 Million Value by 2030, says P&S Intelligence

NEW YORK, July 27, 2022 /PRNewswire/ -- According to the latest market research study published by P&S Intelligence, in 2021, the microarray analysis market was valued at $3,846.7 million, which is on the track to touching $9,011.1 million worth by 2030, advancing at a 9.9% CAGR from 2021 to 2030. The market is primarily driven by the surging incidence of cancer, government-sponsored genomic and proteomic research projects, and increasing use of microarrays.

P and S Intelligence Logo

To stay competitive, the major microarray analysis market players are taking part in several strategic initiatives, including product launches and acquisitions. These key players are Applied Microarrays LLC, Arrayit Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Microarrays Inc., Merck KGaA, GE Healthcare, Illumina Inc., and Agilent Technologies Inc.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/microarray-analysis-market/report-sample

Market Driven by Growing Use of Microarrays in Non-Cancer Applications

Given that bacterial genomic DNA often outlives the actual bacteria in most circumstances, microarray analysis has proven effective in antibiotic treatment. Since a diagnosis may be made using a small amount of DNA, rather than the large number of bacteria needed for a culture in these situations, DNA microarrays are frequently used.

For assessing gene expression, DNA-based microarrays have recently taken the lead. This is primarily driven by the technology's lower cost and complexity of use, which enable it to be standardized and more accepted.

Regional Insights

  • North America held an almost 40% share of the microarray analysis market in 2021. Because the governments of the U.S. and Canada are consistently increasing their funds for cancer research, the region is expected to experience significant growth in the coming years.
  • Furthermore, due to its highly developed healthcare sector, cutting-edge R&D infrastructure, and availability of the related products, Europe is the largest market after North America.

Browse detailed report on Microarray Analysis Market Size, Share, Growth and Demand Forecast to 2030

Segmentation Insights

  • Based on product and service, consumables will advance with over 10% CAGR between 2021 and 2030, due to the increasing number of research institutes and rising usage of microarray analysis at diagnostic laboratories.
  • The software & services category generates the third-highest revenue, as software is extensively utilized to analyze and identify genomes, by studying the data generated during the study.
  • Globally, DNA microarrays accounted for the biggest market share in 2021, and their revenue contribution is expected to grow at a CAGR of almost 10% in the coming years. This is because a variety of disorders have clinical diagnostic procedures that employ DNA microarrays.
  • In 2021, the largest share of the microarray analysis market was held by research and academic institutes, and by 2030, these users would acquire associated products worth over $4.0 billion. This is because the number of projects studying the human genome has increased recently.
  • Similarly, rapid market growth is expected from pharmaceutical and biotechnology firms as a result of the numerous research projects they are conducting for the creation of new medications.

Browse More Reports Published by P&S

Global Protein A Resin Market Size, Share, Growth and Forecast to 2030

Global DNA Extraction Kit Market Share and Growth Analysis Report 2030

Global Gene Therapy Market Size, Share, and Revenue Estimation Through 2030

Global Particle Therapy Market Size, Share, Growth and Demand Forecast to 2030

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg

© 2022 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.